Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Research & Development (2020 - 2025)

Historic Research & Development for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to $86.6 million.

  • IDEAYA Biosciences' Research & Development fell 3822.43% to $86.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $366.9 million, marking a year-over-year increase of 2452.01%. This contributed to the annual value of $314.7 million for FY2025, which is 679.77% up from last year.
  • IDEAYA Biosciences' Research & Development amounted to $86.6 million in Q4 2025, which was down 3822.43% from $83.0 million recorded in Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' Research & Development registered a high of $140.2 million during Q4 2024, and its lowest value of $11.6 million during Q1 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Research & Development value was $28.5 million (recorded in 2023), while the average stood at $41.2 million.
  • As far as peak fluctuations go, IDEAYA Biosciences' Research & Development surged by 26157.6% in 2024, and later plummeted by 3822.43% in 2025.
  • IDEAYA Biosciences' Research & Development (Quarter) stood at $16.1 million in 2021, then surged by 53.4% to $24.7 million in 2022, then skyrocketed by 56.88% to $38.8 million in 2023, then surged by 261.58% to $140.2 million in 2024, then plummeted by 38.22% to $86.6 million in 2025.
  • Its last three reported values are $86.6 million in Q4 2025, $83.0 million for Q3 2025, and $140.2 million during Q4 2024.